Literature DB >> 10211527

Persistent perineal sinus after proctocolectomy for Crohn's disease.

T Yamamoto1, I M Bain, R N Allan, M R Keighley.   

Abstract

PURPOSE: Persistent perineal sinus is a source of morbidity after proctocolectomy for Crohn's disease. This study examined the factors responsible for persistent sinus after proctocolectomy for Crohn's disease. We also assessed the outcome of surgical treatment for persistent perineal sinus.
METHODS: The records of 145 patients who underwent proctocolectomy for Crohn's disease between 1970 and 1997 were reviewed.
RESULTS: Persistent sinus occurred in 33 (23 percent) patients after proctocolectomy. Factors associated with a significantly greater risk of perineal sinus were younger age (P = 0.006), rectal involvement (P = 0.02), perianal sepsis (P = 0.0005), high fistulas (P = 0.04), extrasphincteric excision (P = 0.0004), and fecal contamination at operation (P = 0.0003). Multivariate analyses showed that age (P = 0.0001), rectal involvement (P = 0.007), and fecal contamination (P = 0.009) were significant independent predictive factors for perineal sinus. Fifty-six operations, including 24 radical excisions, two rectus abdominis flaps, four gracilis transpositions, and two omentoplasties were performed in 24 patients with persistent sinus, but only 9 achieved healing. Long sinuses (>10 cm) and sinuses presenting late (>12 weeks after proctocolectomy) were seldom cured by surgical treatment.
CONCLUSION: Persistent perineal sinus is more likely to occur if an extrasphincteric dissection is needed because of extensive anorectal disease or if fecal contamination occurs at operation. Attempted surgical eradication of perineal sinus is often ineffective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211527     DOI: 10.1007/bf02235190

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

1.  [Persistent perineal sinus closure after rectal extirpation-an alternative using bulbocavernosus fat flaps].

Authors:  M Kaminski; M Sippel; A Hirner
Journal:  Chirurg       Date:  2004-06       Impact factor: 0.955

2.  Management of nonhealing perineal wounds.

Authors:  Jill C Genua; David A Vivas
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 3.  Prevention and management of nonhealing perineal wounds.

Authors:  Allen Kamrava; Najjia N Mahmoud
Journal:  Clin Colon Rectal Surg       Date:  2013-06

4.  Persistent perineal sinus after abdominoperineal resection.

Authors:  Amélie Chau; Mathieu Prodeau; Hélène Sarter; Corinne Gower; Moshe Rogosnitzky; Yves Panis; Philippe Zerbib
Journal:  Langenbecks Arch Surg       Date:  2017-08-25       Impact factor: 3.445

Review 5.  Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.

Authors:  Ricardo Sordo-Mejia; Wolfgang B Gaertner
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

6.  Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy.

Authors:  Marco Bertucci Zoccali; Alberto Biondi; Mukta Krane; Essie Kueberuwa; Gianluca Rizzo; Roberto Persiani; Claudio Coco; Roger D Hurst; Domenico D'Ugo; Alessandro Fichera
Journal:  Int J Colorectal Dis       Date:  2014-11-08       Impact factor: 2.571

7.  Efficacy and complications of surgery for Crohn's disease.

Authors:  Robert T Lewis; David J Maron
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-09

Review 8.  Surgical treatment of anorectal crohn disease.

Authors:  Robert T Lewis; Joshua I S Bleier
Journal:  Clin Colon Rectal Surg       Date:  2013-06

Review 9.  Persistent perineal sinus: incidence, pathogenesis, risk factors, and management.

Authors:  Varut Lohsiriwat
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

10.  Guideline proposal to reconstructive surgery for complex perineal sinus or rectal fistula.

Authors:  J W P M Oomen; P H M Spauwen; R P Bleichrodt; H van Goor
Journal:  Int J Colorectal Dis       Date:  2006-03-22       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.